Studies have shown that consuming sesame seeds helps prevent allergies.

Published Date: 06 Mar 2023

Oral desensitization using crushed sesame seeds and tahini may be a safe and effective method to desensitize pediatric patients with sesame allergy...

Read Full News

Latest News

Warning: Patient's Itchy Swollen Skin Patches Were Not Infectious Cellulitis

Five years of inappropriate antibiotic treatment finally ended after proper diagnosis

10-Year Data Back Early Start to Biologics in Arthritic Diseases

— Sustained drug-free remission common in spondyloarthritis patients treated with golimumab

Shingles Recurrence or Something Worse?

Bedside skin punch biopsy proved crucial

Skin Problems, Kidney Complaints, and Venous Issues Spike During Heat Waves

Study suggests attention to heat-related problems besides heat stroke

First Oral Option for Dermatomyositis Gets FDA Green Light

Brepocitinib significantly improved overall symptom status in a phase III trial

A Call to End Routine Laboratory Monitoring for Patients on Isotretinoin

Streamlined testing still overkill given lack of evidence for hepatotoxicity, pancreatitis

Todays Updates

Solengepras Meets Primary Endpoint in Phase 3 ARISE Trial of Parkinson Disease Marco Meglio

Phase 3 ARISE trial results show solengepras 150 mg significantly reduced OFF time and improved motor and non-motor symptoms in Parkinson disease.

Upadacitinib Feasible for Palmoplantar Pustulosis: David Gleeson, BM BCH David Gleeson, BM BCH

Gleeson discusses JAKPPPOT data showing the therapy met all feasibility thresholds with a markedly larger response than historic placebo in PPP.

Nemolizumab Sustains Atopic Dermatitis Skin, Itch Control Through 3 Years

Nemolizumab Sustains Atopic Dermatitis Skin, Itch Control Through 3 Years

Atopic Dermatitis Pipeline and Remibrutinib Approval for Dermographism

Atopic Dermatitis Pipeline and Remibrutinib Approval for Dermographism

Todays Updates

Solengepras Meets Primary Endpoint in Phase 3 ARISE Trial of Parkinson Disease Marco Meglio

Phase 3 ARISE trial results show solengepras 150 mg significantly reduced OFF time and improved motor and non-motor symptoms in Parkinson disease.

Upadacitinib Feasible for Palmoplantar Pustulosis: David Gleeson, BM BCH David Gleeson, BM BCH

Gleeson discusses JAKPPPOT data showing the therapy met all feasibility thresholds with a markedly larger response than historic placebo in PPP.

Nemolizumab Sustains Atopic Dermatitis Skin, Itch Control Through 3 Years

Nemolizumab Sustains Atopic Dermatitis Skin, Itch Control Through 3 Years

Atopic Dermatitis Pipeline and Remibrutinib Approval for Dermographism

Atopic Dermatitis Pipeline and Remibrutinib Approval for Dermographism

Latest News

Five years of inappropriate antibiotic treatment finally ended after proper diagnosis

— Sustained drug-free remission common in spondyloarthritis patients treated with golimumab

Bedside skin punch biopsy proved crucial

Study suggests attention to heat-related problems besides heat stroke

Brepocitinib significantly improved overall symptom status in a phase III trial

Streamlined testing still overkill given lack of evidence for hepatotoxicity, pancreatitis

News All Time

US Regulators Urge More Research on Testosterone Therapy for Women as Experts Debate Benefits, Risks

US health regulators on Thursday called for more data on testosterone therapies for women, with FDA officials urging manufacturers to conduct studies that could support...

FDA Grants Priority Review for Diabetic Foot Ulcer Therapy

The FDA has granted priority review for a novel wound-healing therapy for Wagner Grade 1 diabetic foot ulcers.

Pennsylvania Measles Cases Top 700 After Four Outbreak-related Deaths Reported

The Pennsylvania Department of Health on Wednesday reported 731 measles cases, up 38 from Monday's ⁠update, as the outbreak continued to spread in the state at the center of...

Fear of Relapse Burdens Patients With Vitiligo

Nearly half of patients with vitiligo who achieve repigmentation fear losing treatment gains, with relapse-related anxiety affecting psychological well-being even when skin improvement is maintained.

Adding IVIG to Prednisone Boosts Outcomes in IIMs

IVIG plus high-dose prednisone leads to improved disease activity and a faster response in newly diagnosed idiopathic inflammatory myopathies, but clotting remains a concern.

Smoke Exposure Tied to HS Risk in Children and Teens

Both passive and active exposure were associated with increased odds of diagnosis in pediatric and adolescent patients with hidradenitis suppurativa, a study reports.

A Decade After Mercury Ban, Toxic Skin Bleachers Still Offered on Top Retailers' Websites

(Removes errant quote marks in paragraph 14)

Pennsylvania Measles-associated Deaths Climb to Four as Outbreak Grows

The Pennsylvania Department of Health on Tuesday reported two more measles-associated deaths, both in unvaccinated individuals, bringing the state's total fatalities linked...

FDA Grants Priority Review to Zasocitinib for Psoriasis

Zasocitinib is also being evaluated in phase 3 studies for psoriatic arthritis and in phase 2 studies for Crohn’s disease, ulcerative colitis, vitiligo, and hidradenitis suppurativa.

Serious Infections Lower With Anifrolumab in CLE Patients

Anifrolumab, approved for systemic lupus, is currently being evaluated in a phase 3 study in patients with cutaneous lupus erythematosus.

COVID, 6 Years on: The Pandemic’s Long Clinical Shadow

Although acute COVID is generally less severe today, long COVID, limited treatment options, and ongoing controversy still define the pandemic’s aftermath.

Prior Keratinocyte Carcinoma Tied to Mucosal Melanoma

A history of keratinocyte carcinoma was associated with more than four times the odds of mucosal melanoma, study reports.

Trust in Measles Vaccines Falls in US, Reuters Ipsos Poll Finds

Americans' trust in vaccines for deadly childhood diseases including measles has fallen in recent years, a new Reuters/Ipsos poll found, a troubling sign for the country as...

Arizona Accuses L'Oreal Of Concealing Cancer Risks Linked to Hair Relaxers

Arizona has sued L'Oreal SA and its U.S. subsidiary, alleging the cosmetics company hid evidence that its hair relaxer products could cause cancer ⁠in women, as it faces...

Pembrolizumab Benefits Persist in Cervical Cancer

After 5 years of follow-up, pembrolizumab plus chemotherapy continues to demonstrate sustained survival advantages in patients with persistent, recurrent, or metastatic cervical cancer.

Criteria for Prescribing Testosterone: Who Qualifies?

A Brazilian multidisciplinary consensus sets thresholds for the diagnosis and treatment while emphasizing symptom assessment, repeated testing, and attention to the underlying causes.

Recommended News For You

'Converging' Evidence of Link Between Air Pollution and Breast Cancer

AI-based liquid biopsy shows promise for detecting brain cancer

Reasons Behind Refusing Stem Cell Transplantation in Certain Myeloma Patients.

Dr. Prerana S. Nesargi's message for Childhood Cancer Awareness Month 2023 is to increase understanding of pediatric oncology.

Updates from the 2022 WHO classification of kidney epithelial tumors

Cancer cells with thick glycocalyx barrier evade immune system better: study

Defibrotide Prophylaxis May Reduce SOS Risk After HSCT

Recommended Articles For You

Case Study: Revolutionizing PNH Treatment with Eculizumab for Superior Patient Outcomes 

Cancer Vaccines in Solid Tumors: Current Landscape, Mechanisms, and Clinical Implications 

Unlocking the Power of Hematocrit: Exploring the Benefits of Blood Cell Counts 

Unraveling the Mysteries of Lymphoma: A Journey into the Unknown 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Report: Breast cancer mortality continues three decade decline, but steeper increases in incidence for some women

2.

Chronic pain and poor sleep are troublesome bed partners.

3.

Retired Olympic athletes at greater risk of skin cancer and osteoarthritis, research reveals

4.

Upfront TKI for Bone-Predominant RCC Tops Single-Agent Immunotherapy

5.

New study elucidates obesity's role in fueling breast cancer progression

1.

A Closer Look at MCV Modules: Features, Functions, and Benefits 

2.

Minimal Residual Disease Monitoring: Advances, Clinical Relevance, and Guideline-Based Perspectives

3.

Ethics of Experimental Oncology: Case Study on Autonomy, Consent & Decision-Making

4.

The Role of Calcium Corrections in Accurate Blood Test Results 

5.

Oncology Drug Handling Near-Misses: Clinical Risks, Pathophysiology, and Guideline-Based Approaches

1.

International Conference on Oncology, Cardiology and Critical Care Policy

2.

International Conference on Innovations in Critical Care for Oncology and Cardiology

3.

International Conference on Oncology, Cancer Prevention and Public Health

4.

International Conference on Cancer Nursing and Rehabilitation Strategies

5.

International Conference on Cancer Nursing and Hematology Support

1.

Current Scenario of Blood Cancer- Genomic Testing & Advancement in Diagnosis and Treatment

2.

Future of Hematology

3.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I

4.

Efficient Management of First line ALK-rearranged NSCLC - Part V

5.

Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot